Aqumen Biopharmaceuticals' Other Investors

Aqumen Biopharmaceuticals raised a round of funding on , . Investors include Mitsubishi UFJ Capital.

The company's current portfolio of compounds and technologies in the development pipeline includes: i) A0001, Ophthalmic Dye for Retinal Surgery ii) A0003, treatments for Age-related Macular Degenerat…

Articles about Aqumen Biopharmaceuticals' Other Investors: